dc.contributor.author |
Motwakil Imam Awadelkareim Imam |
|
dc.date.accessioned |
2025-05-14T09:04:23Z |
|
dc.date.available |
2025-05-14T09:04:23Z |
|
dc.date.issued |
2022-04-01 |
|
dc.identifier.citation |
Dr. Motwakil Imam Awadelkareim Imam , Graves's Disease Is Associated with Pancytopenia and Splenomegaly Response to Steroid Therapy.(2025).Int J Pharm Sci.16(1), p63-68 http://dx.doi.org/10.22376/ijpbs.2025.16.1.p63-68 |
en_US |
dc.identifier.issn |
1341-2051 |
|
dc.identifier.uri |
http://repository.ush.edu.sd:8080/xmlui/handle/123456789/1030 |
|
dc.description |
ABSTRACT— COVID-19 is RNA virus was identified in 2019 in Wuhan, China and it causes a various
degree of respiratory affection ranging from mild respiratory illness to life threatening respiratory failure.
The main diagnostic test is detection of the virus by PCR in a nasopharyngeal swab. We aimed to determine
the incidence, clinical presentation, and outcome of COVID-19 patients in a limited resources setting. We
included 258 COVID-19 cases from Shendi isolation center, Sudan. This study was conducted during the
period between November 2020 and June 2021. The most common age group was found to be between 61
—80years representing 46.5% of the patients. More than half of them were males. The clinical presentations
of the patients were dominated by the following profile: Fever in 211 patients (81.8%), dyspnea in 169
patients (65.5%), cough in 160 patients (62%), sore throat in 49 patients (19%), headache in 21 patients
(8.1%), fatigue in 14 patients (5.4%), chest pain in 7 patients (2.7%), anosmia in 6 patients (2.3%), loss of
appetite in 5 patients (1.9%), abdominal pain in 2 patients (0.8%), diarrhea in 2 patients (0.8%), vomiting in
one patient (0.4%), loss of test in 3 patients (1.2%), nausea in one patient )0.4%(, and rhinorrhea in one
patient (0.4%). Most of patients were from rural areas (67.8%). The most common chronic illness seen was
DM in 58 patients (22.5%) and hypertension in 43 patients (16.7%). Mortality rate was (28.7%) (affecting
74 patients), In COVID-19, the most common presenting symptoms are: fever, cough and dyspnea are.
Mortality rate is found to be very high in this study; both DM and hypertension are associated with
increased incidence and mortality rate of COVID-19. The mortality rate is directly proportionate to increase
in age; as the age group 61-80 representing 46.5% of the patients. |
en_US |
dc.description.abstract |
ABSTRACT— COVID-19 is RNA virus was identified in 2019 in Wuhan, China and it causes a various
degree of respiratory affection ranging from mild respiratory illness to life threatening respiratory failure.
The main diagnostic test is detection of the virus by PCR in a nasopharyngeal swab. We aimed to determine
the incidence, clinical presentation, and outcome of COVID-19 patients in a limited resources setting. We
included 258 COVID-19 cases from Shendi isolation center, Sudan. This study was conducted during the
period between November 2020 and June 2021. The most common age group was found to be between 61
—80years representing 46.5% of the patients. More than half of them were males. The clinical presentations
of the patients were dominated by the following profile: Fever in 211 patients (81.8%), dyspnea in 169
patients (65.5%), cough in 160 patients (62%), sore throat in 49 patients (19%), headache in 21 patients
(8.1%), fatigue in 14 patients (5.4%), chest pain in 7 patients (2.7%), anosmia in 6 patients (2.3%), loss of
appetite in 5 patients (1.9%), abdominal pain in 2 patients (0.8%), diarrhea in 2 patients (0.8%), vomiting in
one patient (0.4%), loss of test in 3 patients (1.2%), nausea in one patient )0.4%(, and rhinorrhea in one
patient (0.4%). Most of patients were from rural areas (67.8%). The most common chronic illness seen was
DM in 58 patients (22.5%) and hypertension in 43 patients (16.7%). Mortality rate was (28.7%) (affecting
74 patients), In COVID-19, the most common presenting symptoms are: fever, cough and dyspnea are.
Mortality rate is found to be very high in this study; both DM and hypertension are associated with
increased incidence and mortality rate of COVID-19. The mortality rate is directly proportionate to increase
in age; as the age group 61-80 representing 46.5% of the patients. |
en_US |
dc.description.sponsorship |
Shendi University |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
International Medical Journal |
en_US |
dc.relation.ispartofseries |
Volume 29,;Issue 04, April, 2022 |
|
dc.subject |
COVID-19 |
en_US |
dc.subject |
Clinical presentation |
en_US |
dc.subject |
Incidence; |
en_US |
dc.subject |
Outcome; Sudan |
en_US |
dc.title |
Prevalence and Outcome of COVID -19 in A Limited- Resource Setting, A cross- sectional Study, Sudan, 2021 |
en_US |
dc.type |
Article |
en_US |